AI assistant
Sending…
Moberg Pharma — Major Shareholding Notification 2024
May 22, 2024
3174_iss_2024-05-22_27d078fb-36db-41e2-8fa4-3f8a98a38ff9.pdf
Major Shareholding Notification
Open in viewerOpens in your device viewer

Issuer Moberg Pharma AB (publ)
Holder
Avanza Bank Holding AB för Försäkringsaktiebolaget Avanza Pension
| Instrument | |
|---|---|
| Instrument | Aktier |
| Before the transaction | |
| Shares | Data not given* |
| Voting rights | Data not given* |
| Transaction | |
| Reason for major shareholding notification Sell | |
| Date | 21/05/2024 |
| Limit for number of shares | 5 % |
| Limit for number of votes | 5 % |
| After the transaction | |
| Quantity | |
| Shares | 1,417,214 |
| Directly held voting rights | 0 |
| Indirectly held voting rights | 1,417,214 |
| Percentage | |
| Directly held shares | 4.98888 % |
| Directly held voting rights | 0 % |
| Indirectly held voting rights | 4.98888 % |
Resulting distribution of total holdings
| Shares | Percentage of voting rights: |
Number of underlying shares: |
|
|---|---|---|---|
| 4.98888 % | 1,417,214 | ||
| Instruments - FITA Ch. 4, section 2, first paragraph, line 2 Instruments - FITA Ch. 4, section 2, first paragraph, line 3 |
|||
| - Physically settled - Cash settled |
|||
| Total | 4.98888 % | 1,417,214 | |
| Group total holdings |
|||
| Voting rights | 1,417,214 | ||
| Percentage of voting rights 4.98888 | |||
| Notes (other relevant informations according to law) | |||
| Aktierna innehas av Försäkringsaktiebolaget Avanza Pension som är ett helägt dotterbolag till |
Avanza Bank Holding AB (publ). Det är försäkringskunder som via depåfullmakt har avyttrat de aktuella aktierna.
Published
22/05/2024 13:20
Contact
- Name Marie Karlsfeldt
- Email [email protected]
*Source of information has chosen not to submit the data
CLOSE PRINT
[email protected] Tfn 08-408 980 37 Fax 08-24 39 25
More from Moberg Pharma
Declaration of Voting Results & Voting Rights Announcements
2026
May 21
Declaration of Voting Results & Voting Rights Announcements
2026
May 21
Interim / Quarterly Report
2026
May 12
Interim / Quarterly Report
2026
May 12
Regulatory Filings
2026
Apr 24
Regulatory Filings
2026
Apr 24
Proxy Solicitation & Information Statement
2026
Apr 17
AGM Information
2026
Apr 17
Annual Report
2026
Apr 17
Regulatory Filings
2026
Mar 13